Muhammad Hassan Raza1, Kamni Gul1, Abida Arshad2, Naveeda Riaz1, Usman Waheed3, Abdul Rauf4, Fahad Aldakheel5, Shatha Alduraywish6, Maqbool Ur Rehman1, Muhammad Abdullah1, Muhammad Arshad7. 1. Department of Bioinformatics and Biotechnology, International Islamic University, Islamabad, Pakistan. 2. Department of Biology, PMAS-Arid Agriculture University, Rawalpindi, Pakistan. 3. Department of Pathology and Blood Bank, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan. 4. Department of Zoology, Azad Jammu and Kashmir University, Muzaffarabad, Pakistan. 5. Department of Clinical Laboratory Medicine, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia. 6. Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia. 7. Department of Bioinformatics and Biotechnology, International Islamic University, Islamabad, Pakistan. m.arshad@iiu.edu.pk.
Abstract
PURPOSE: Human microbiota comprises of a variety of organisms ranging from bacterial species to viruses, fungi, and protozoa which are present on the epidermal and mucosal barriers of the body. It plays a key role in health and survival of the host by regulation of the systemic functions. Its apparent functions in modulation of the host immune system, inducing carcinogenesis and regulation of the response to the cancer therapy through a variety of mechanisms such as bacterial dysbiosis, production of genotoxins, pathobionts, and disruption of the host metabolism are increasingly becoming evident. METHODS: Different electronic databases such as PubMed, Google Scholar, and Web of Science were searched for relevant literature which has been reviewed in this article. RESULTS: Characterization of the microbiome particularly gut microbiota, understanding of the host-microbiota interactions, and its potential for therapeutic exploitation are necessary for the development of novel anticancer therapeutic strategies with better efficacy and lowered off-target side effects. CONCLUSION: In this review, the role of microbiota is explained in carcinogenesis, mechanisms of microbiota-mediated carcinogenesis, and role of gut microbiota in modulation of cancer therapy.
PURPOSE:Human microbiota comprises of a variety of organisms ranging from bacterial species to viruses, fungi, and protozoa which are present on the epidermal and mucosal barriers of the body. It plays a key role in health and survival of the host by regulation of the systemic functions. Its apparent functions in modulation of the host immune system, inducing carcinogenesis and regulation of the response to the cancer therapy through a variety of mechanisms such as bacterial dysbiosis, production of genotoxins, pathobionts, and disruption of the host metabolism are increasingly becoming evident. METHODS: Different electronic databases such as PubMed, Google Scholar, and Web of Science were searched for relevant literature which has been reviewed in this article. RESULTS: Characterization of the microbiome particularly gut microbiota, understanding of the host-microbiota interactions, and its potential for therapeutic exploitation are necessary for the development of novel anticancer therapeutic strategies with better efficacy and lowered off-target side effects. CONCLUSION: In this review, the role of microbiota is explained in carcinogenesis, mechanisms of microbiota-mediated carcinogenesis, and role of gut microbiota in modulation of cancer therapy.
Entities:
Keywords:
Cancer therapy; Carcinogenesis; Gut microbiota; Microbiome
Authors: Rheinallt M Jones; Chirayu Desai; Trevor M Darby; Liping Luo; Alexandra A Wolfarth; Christopher D Scharer; Courtney S Ardita; April R Reedy; Erin S Keebaugh; Andrew S Neish Journal: Cell Rep Date: 2015-08-13 Impact factor: 9.423
Authors: Masayuki Fukata; Limin Shang; Rebeca Santaolalla; John Sotolongo; Cristhine Pastorini; Cecilia España; Ryan Ungaro; Noam Harpaz; Harry S Cooper; Greg Elson; Marie Kosco-Vilbois; Julia Zaias; Maria T Perez; Lloyd Mayer; Arunan S Vamadevan; Sergio A Lira; Maria T Abreu Journal: Inflamm Bowel Dis Date: 2010-11-15 Impact factor: 5.325
Authors: Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya Journal: World J Gastroenterol Date: 2014-02-07 Impact factor: 5.742
Authors: Diana Kao; Laura Flores-Bocanegra; Huzefa A Raja; Blaise A Darveaux; Cedric J Pearce; Nicholas H Oberlies Journal: Phytochemistry Date: 2020-01-10 Impact factor: 4.072
Authors: Isabela M Di Chiacchio; Elena Gómez-Abenza; Isadora M Paiva; Danilo J M de Abreu; Juan Francisco Rodríguez-Vidal; Elisângela E N Carvalho; Stephan M Carvalho; Luis David Solis-Murgas; Victoriano Mulero Journal: Sci Rep Date: 2022-06-15 Impact factor: 4.996
Authors: Se Ik Kim; Nayeon Kang; Sangseob Leem; Jinho Yang; HyunA Jo; Maria Lee; Hee Seung Kim; Danny N Dhanasekaran; Yoon-Keun Kim; Taesung Park; Yong Sang Song Journal: Cancers (Basel) Date: 2020-05-21 Impact factor: 6.639
Authors: Byeongsang Oh; Thomas Eade; Gillian Lamoury; Susan Carroll; Marita Morgia; Andrew Kneebone; George Hruby; Mark Stevens; Frances Boyle; Stephen Clarke; Brian Corless; Mark Molloy; David Rosenthal; Michael Back Journal: Cancers (Basel) Date: 2021-05-13 Impact factor: 6.639
Authors: Aroa Lopez-Santamarina; Alicia Del Carmen Mondragon; Alexandre Lamas; Jose Manuel Miranda; Carlos Manuel Franco; Alberto Cepeda Journal: Foods Date: 2020-06-12